Core Viewpoint - The article emphasizes the importance of evaluating medical technologies based on their long-term clinical integration and practical utility rather than just their initial market launch or flashy presentations. Sonopet, an ultrasonic aspirator system, exemplifies a technology that has proven its value through extensive clinical use and continuous improvement over two decades [2][19]. Group 1: Product Evolution and Clinical Journey - Sonopet originated in Japan and was acquired by Stryker in 2009, initially marketed as a soft tissue removal tool for complex surgeries, particularly for calcified brain tumors [4][5]. - The system has evolved to include a "universal handle + interchangeable tip" design, allowing for applications across multiple specialties, including neurosurgery and orthopedics [4][5]. - Sonopet's initial device demonstrated high efficiency in tissue fragmentation and has shown the ability to replace traditional surgical tools in various procedures [5]. Group 2: Clinical Validation and Usage - In neurosurgery, Sonopet is used for safe tumor resection, with studies indicating reduced intraoperative bleeding and an average surgery time reduction of approximately 15% compared to traditional methods [6]. - The system is also utilized in orthopedic procedures, where its linear ultrasonic vibration minimizes vibration and debris, making it suitable for minimally invasive approaches [6][8]. - Sonopet has gained acceptance in ENT and maxillofacial surgeries due to its controlled tissue destruction and low thermal damage, becoming a common tool in these fields [6][7]. Group 3: Technical Features and Innovations - Sonopet employs low-frequency ultrasonic technology, allowing for precise control of energy output to effectively emulsify tissue without overheating or excessive vibration [11][13]. - The system features a real-time perfusion-aspiration integrated pathway, which helps reduce surgical field obscurity and the risk of clogging, thereby lowering postoperative infection rates [11][13]. - The platform design of Sonopet allows for a variety of interchangeable tips, enhancing its versatility across different surgical disciplines [15][16]. Group 4: Market Strategy and Future Outlook - Stryker is focusing on localizing its research and manufacturing efforts in China, aiming to provide solutions that meet both global standards and local clinical needs [18][21]. - The company plans to launch its first domestically produced ultrasonic surgical system by the end of 2025, indicating a commitment to expanding its footprint in the Chinese market [21].